Startups

Breakthrough Diagnostics, LLC

globenewswire.comnjeda.govfoundationventure.com

Breakthrough Diagnostics, LLC is an institutional investor in Durin Technologies, the neurodegenerative-disease blood-test business later branded Durin Life Sciences. Durin’s December5,2023 issuer release explicitly identifies this LLC as lead investor in a USD3.5M financing announcement. New Jersey Economic Development Authority investment-tax-credit records independently name the LLC as a Durin investor, and its2025program table locates the applicant in Great Falls, Fairfax County, Virginia. Foundation Venture Capital Group also reports that it sold its Durin equity interest to this LLC, a separate historical secondary transaction with undisclosed price and date. The entity is recorded as a company/institutional investor, rather than presumed to be a public venture manager or LP fund. No official website, authentic entity logo, confirmed public LLC management roster, or outside fund close has been established. Similarly named Breakthrough Diagnostics Inc. businesses—including the Nevada Todos/Amarantus diagnostic subsidiary and an Inc. named in Ric Edelman’s regulatory disclosure—are not merged without exact legal continuity proof. Durin board members and personal investments are kept separate from the LLC’s subscriptions. Tax-credit approval dates and amounts are not treated as company funding-close dates or investor checks.

Team

No team members on record yet.

Investments